[go: up one dir, main page]

FI884691L - Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi - Google Patents

Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi Download PDF

Info

Publication number
FI884691L
FI884691L FI884691A FI884691A FI884691L FI 884691 L FI884691 L FI 884691L FI 884691 A FI884691 A FI 884691A FI 884691 A FI884691 A FI 884691A FI 884691 L FI884691 L FI 884691L
Authority
FI
Finland
Prior art keywords
lysostaphin
producing
product
dna fragment
same
Prior art date
Application number
FI884691A
Other languages
English (en)
Swedish (sv)
Other versions
FI96322B (fi
FI884691A0 (fi
FI96322C (fi
Inventor
Paul A Recsei
Original Assignee
New York Health Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Health Res Inst filed Critical New York Health Res Inst
Publication of FI884691L publication Critical patent/FI884691L/fi
Publication of FI884691A0 publication Critical patent/FI884691A0/fi
Publication of FI96322B publication Critical patent/FI96322B/fi
Application granted granted Critical
Publication of FI96322C publication Critical patent/FI96322C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
FI884691A 1986-04-16 1988-10-12 Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi FI96322C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US85240786A 1986-04-16 1986-04-16
US85240786 1986-04-16
US07/034,464 US4931390A (en) 1986-04-16 1987-04-10 Expression of the cloned lysostaphin gene
US3446487 1987-04-10
US8700873 1987-04-15
PCT/US1987/000873 WO1987006264A1 (en) 1986-04-16 1987-04-15 Expression of the cloned lysostaphin gene

Publications (4)

Publication Number Publication Date
FI884691L true FI884691L (fi) 1988-10-12
FI884691A0 FI884691A0 (fi) 1988-10-12
FI96322B FI96322B (fi) 1996-02-29
FI96322C FI96322C (fi) 1996-06-10

Family

ID=26710985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884691A FI96322C (fi) 1986-04-16 1988-10-12 Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi

Country Status (15)

Country Link
US (1) US4931390A (fi)
EP (1) EP0299978B1 (fi)
JP (1) JP2963695B2 (fi)
AT (1) ATE92524T1 (fi)
AU (1) AU616379B2 (fi)
CA (1) CA1297051C (fi)
DE (1) DE3786918T2 (fi)
DK (1) DK174941B1 (fi)
FI (1) FI96322C (fi)
HU (1) HU205386B (fi)
IE (1) IE60769B1 (fi)
IL (1) IL82260A (fi)
NZ (1) NZ219998A (fi)
PT (1) PT84705B (fi)
WO (1) WO1987006264A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260212A (en) * 1987-02-09 1993-11-09 Quest International Flavors & Food Ingredients Co., Division Of Indopco Cloned gene encoding for bacteriocin from Pediococcus acidilactici
US5858962A (en) * 1987-05-11 1999-01-12 Ambi Inc. Composition for treating mastitis and other staphylococcal infections
US5011772A (en) * 1988-02-05 1991-04-30 Public Health Research Institute Of The City Of N.Y. High yield protein production system
HUT53154A (en) * 1988-05-05 1990-09-28 New York Health Res Inst Process for producing protease-defective gram-positive bacteria and utilizing them as host-organizmus for producing recombinant products
CA2009336A1 (en) * 1989-07-03 1991-01-03 Peter A. Vandenbergh Cloned gene encoding for bacteriocin from pediococcus acidilactici
DE4425645A1 (de) * 1994-07-20 1996-02-22 Mueller Karl & Co Kg Deletiertes Lysostaphingen von Staphylococcus simulans
EP0833657B1 (en) * 1995-06-23 2003-08-27 AMBI Inc. A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
WO1997008553A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Targeting of proteins to the cell wall of gram-positive bacteria
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
US6875903B2 (en) * 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections
AU4706799A (en) * 1998-06-22 2000-01-10 University Of Vermont And State Agricultural College, The Treatment of (staphylococcus) infections
JP4416866B2 (ja) * 1998-07-30 2010-02-17 オリエンタル酵母工業株式会社 カルシウム測定用液状試薬
US6569830B1 (en) * 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
ATE430799T1 (de) * 1999-10-19 2009-05-15 Bharat Biotech International L Expression von rekombinantem, reifem lysostaphin
CA2469720A1 (en) * 2001-12-21 2003-10-09 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
US7452533B2 (en) * 2002-03-26 2008-11-18 Biosynexus Incorporated Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol
BR0308285A (pt) * 2002-03-26 2005-04-12 Biosynexus Inc Ruptura de biofilmes bacterianos por meio de enzimas
US20100221237A1 (en) * 2003-03-26 2010-09-02 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
US7488789B2 (en) 2003-03-28 2009-02-10 Mitsui Chemicals, Inc. Propylene copolymer, polypropylene composition, and uses thereof, transition metal compounds and catalyst for olefin polymerization
CN100485031C (zh) * 2004-09-02 2009-05-06 上海高科联合生物技术研发有限公司 一种溶葡萄球菌酶工业化纯化工艺
US8273339B2 (en) * 2005-04-12 2012-09-25 Nektar Therapeutics Polymer-based compositions and conjugates of antimicrobial agents
CN100475965C (zh) * 2005-07-22 2009-04-08 上海高科联合生物技术研发有限公司 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法
WO2008105826A2 (en) * 2006-09-05 2008-09-04 Biosynexus Incorporated Compositions compromising lysostaphin variants and methods of using the same
CA2692800A1 (en) * 2007-07-09 2009-01-15 Christopher John Stanley Detection of micro-organisms based on their nad-dependent dna ligase activity
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
WO2012050787A1 (en) 2010-09-29 2012-04-19 Ibis Biosciences, Inc. Fungal nucleic acid extraction
WO2015020765A2 (en) * 2013-08-06 2015-02-12 Trustees Of Dartmouth College Unglycosylated lysostaphin variant protein
EP3086805B1 (en) 2013-12-28 2018-10-03 Longhorn Vaccines and Diagnostics, LLC Use of glycyl-glycine endopeptidase for treating mycobacteria infections
CN106795506B (zh) 2014-05-14 2020-11-27 达特茅斯学院理事会 去免疫化溶葡萄球菌酶和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278378A (en) * 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US4467036A (en) * 1981-11-12 1984-08-21 The Board Of Regents Of The University Of Washington Bacillus thuringiensis crystal protein in Escherichia coli
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A

Also Published As

Publication number Publication date
PT84705A (en) 1987-05-01
EP0299978A1 (en) 1989-01-25
CA1297051C (en) 1992-03-10
IE870980L (en) 1987-10-16
AU616379B2 (en) 1991-10-31
FI96322B (fi) 1996-02-29
JPH01503036A (ja) 1989-10-19
FI884691A0 (fi) 1988-10-12
AU7302187A (en) 1987-11-09
DK659287D0 (da) 1987-12-15
EP0299978B1 (en) 1993-08-04
DK659287A (da) 1987-12-15
US4931390A (en) 1990-06-05
IE60769B1 (en) 1994-08-10
DE3786918D1 (de) 1993-09-09
FI96322C (fi) 1996-06-10
DK174941B1 (da) 2004-03-08
HU205386B (en) 1992-04-28
IL82260A (en) 1992-08-18
NZ219998A (en) 1991-05-28
ATE92524T1 (de) 1993-08-15
JP2963695B2 (ja) 1999-10-18
HUT50874A (en) 1990-03-28
DE3786918T2 (de) 1993-11-11
IL82260A0 (en) 1987-10-30
PT84705B (pt) 1989-11-30
WO1987006264A1 (en) 1987-10-22

Similar Documents

Publication Publication Date Title
FI884691L (fi) Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi
FI880845L (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
IT8423351A0 (it) Procedimento per produrre fattore viii mediante tecnica a dna ricombinante e relativi prodotti.
EP0177568A4 (en) RECOMBINANT DNA MOLECULES.
OA08707A (en) Tertiary hydroxyalkylxanthines, processes for their preparation, medicaments containing them and their use.
DE68924227D1 (de) DNA-Fragment.
FI871288L (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
FI854994L (fi) Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DE3680403D1 (de) Asphaltverkokungsverfahren.
EP0177915A3 (en) Novel dna, production and use thereof
SE8204810D0 (sv) Recombinant dna molecule, transformed microorganism and process for producing protein a
NO845132L (no) Humant interferon-ypsilon-polypeptidderivat, fremgangsmaate for fremstilling derav og rekombinant plasmid inneholdende et dna-fragment som koder for polypeptidet
EP0186628A3 (en) Pentaerythritdiphosphites, process for their preparation and their use as stabilizers
HUT45061A (en) Process for producing thieno-isoxazoles and-pyrazoles, and pharmaceuticals comprising these compounds and decreasing blood-pressure
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
DK160945C (da) Humant interferon-gamma-polypeptid og fremgangsmaade til fremstilling deraf, rekombinant plasmid omfattende et dna-fragment, som koder for peptidet, og mikroorganisme transformeret med plasmidet
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
AU2820992A (en) Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same
EP0221146A4 (en) REGULATION OF THE SEPARATION POINT IN DISTILLATION.
EP0183006A3 (en) A recombinant dna-molecule, coryneform bacteria carrying recombinant dna and process for producing an aromatic amino acid by using the same
IT8619033A0 (it) Macchina per produrre fili torti o ritorti.
DE3781865D1 (de) Klonierung von dns, welche einen menschlichen gip-vorlaeufer kodiert und expressionsverfahren des vorlaeufers.
IT8619532A0 (it) Macchina per produrre fili torti o ritori.
DK151788D0 (da) Hybridserpiner og dna, som koder derfor

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: APPLIED MICROBIOLOGY, INC.

MA Patent expired